机译:非核苷逆转录酶抑制剂(NNRTI)交叉抗性:对新型NNRTIS和临床基因型抗性试验的临床前评价的影响
Department of Medicine Stanford University Stanford CA United States;
Department of Medicine Stanford University Stanford CA United States;
Department of Medicine Stanford University Stanford CA United States;
Gilead Sciences Foster City CA United States;
Gilead Sciences Foster City CA United States;
Department of Statistics Stanford University Stanford CA United States;
Department of Medicine Kaiser Permanente Medical Care Program Los Angeles CA United States;
Division Infectious Diseases UC Davis Medical Center CA United States;
East Bay AIDS Center Alta Bates Summit Medical Center Oakland CA United States;
Orlando Immunology Center Orlando FL United States;
Infectious Diseases Massachusetts General Hospital and Harvard Medical School Boston MA United;
Palo Alto Medical Foundation Palo Alto CA United States;
Quest Diagnostics San Juan Capistrano CA United States;
Kaiser Permanente Medical Care Program Northern California San Francisco CA United States;
Department of Medicine Stanford University Stanford CA United States;
Department of Medicine Stanford University Stanford CA United States;
Department of Medicine Stanford University Stanford CA United States;
Drug resistance; Etravirine; HIV-1; Linear regression; Rilpivirine;
机译:非核苷逆转录酶抑制剂(NNRTI)交叉耐药性:对新型NNRTIs的临床前评估和临床基因型耐药性测试的意义
机译:lersivirine与etravirine在先前使用非核苷类逆转录酶抑制剂(NNRTI)的患者中治疗HIV-1感染的有效性和安全性以及NNRTI耐药性的证据:一项2B期随机试验。
机译:设计,合成和临床前评估新型的4-取代的1,5-二芳基苯胺作为有效的HIV-1非核苷逆转录酶抑制剂(NNRTI)候选药物
机译:AlGaN / GaN高电子迁移率晶体管对HIV-1的非核苷逆转录酶抑制剂(NNRTIs)的新型检测
机译:人类免疫缺陷病毒1型逆转录酶突变体对非核苷类逆转录酶抑制剂的生化特性
机译:非核苷逆转录酶抑制剂(NNRTI)交叉耐药性:对新型NNRTIs的临床前评估和临床基因型耐药性测试的意义
机译:NNRTI(非核苷逆转录酶抑制剂)药物AZT及其制备与测定eFaviraenz的专利评价